Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Cancer risk established before birth
A person’s lifetime risk for cancer may begin before they are even born, reports a…
New research helps explain why cancer risk declines in old age
When it comes to cancer, ageing is a double-edged sword, researchers are increasingly learning. Age…
Study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system
Effective immunity hinges on the ability to sense infection and cellular transformation. In humans, there…
Potential new treatment for prostate cancer receives $5M funding boost
- Scientists now able to predict response to radium-223 treatment in prostate cancer bone metastases
- Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
- Studies help explain why some prostate cancers become resistant to hormone therapy
Cervical cancer is a disease of inequity: here’s how to save 60 million lives
Lynette Denny, University of Cape Town The World Health Organization estimates that cancer a leading cause of death around the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.